SEI Investments
LFCR icon

SEI Investments’s Lifecore Biomedical LFCR Stock Holding History

SEI Investments’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-20
Closed – – 3020
2018
Q2 		$0 Buy
+20
New +$278 ﹤0.01% 3718
2015
Q4 		– Sell
-25,714
Closed -$300K – 2615
2015
Q3 		$300K Buy
+25,714
New +$341K ﹤0.01% 1479

Other funds holding LFCR

NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
WC
Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

SEI Investments's LFCR Position: Q3 2018 in Review

SEI Investments sold out of Lifecore Biomedical (LFCR) in Q3 2018, closing a stake of 20 shares.

SEI Investments first reported a position in LFCR in Q3 2015 and held it in 2 quarters. The position peaked at $300K in Q3 2015. 90 funds tracked by Wall St. Rank hold LFCR as of Q3 2018.

  • SEI Investments reported no remaining Lifecore Biomedical position as of Q3 2018 after selling out during the quarter.
  • SEI Investments sold 20 Lifecore Biomedical shares in Q3 2018.
  • SEI Investments first reported a position in Lifecore Biomedical in Q3 2015 and held it in 2 quarters.
  • SEI Investments's Lifecore Biomedical position peaked at $300K in Q3 2015.
  • 90 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2018.

Based on SEI Investments's 13F filing for Q3 2018, filed 8 Nov 2018.